| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Henry T Peng | |
| P2860 | cites work | Evaluation of a Novel Fibrin Sealant Patch in Hemorrhage Control After Vascular or Hepatic Injury | Q90210187 |
| Feasibility of prehospital freeze-dried plasma administration in a UK Helicopter Emergency Medical Service | Q90368378 | ||
| Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial | Q90391638 | ||
| Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock | Q90468209 | ||
| What is the impact of prehospital blood product administration for patients with catastrophic haemorrhage: an integrative review | Q90709342 | ||
| Transfusion strategies for major haemorrhage in trauma | Q90787209 | ||
| Clinical pharmacology, efficacy and safety study of a triple-secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiency | Q91127245 | ||
| Systematic review of prehospital haemostatic dressings | Q91318559 | ||
| Challenges to producing novel therapies - dried plasma for use in trauma and critical care | Q91431695 | ||
| Pre-hospital plasma transfusion: a valuable coagulation support or an expensive fluid therapy? | Q91523161 | ||
| Pilot Study of a Novel Swine Model for Controlling Junctional Hemorrhage Using the iTClamp in Conjunction With Hemostatic Agents | Q92554795 | ||
| Is prehospital blood transfusion effective and safe in haemorrhagic trauma patients? A systematic review and meta-analysis | Q92716313 | ||
| Trauma-targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model | Q92905596 | ||
| A review on recent advances in chitosan based composite for hemostatic dressings | Q93188133 | ||
| Safety evaluation of a lyophilized platelet-derived hemostatic product | Q93203962 | ||
| Efficacy of a haemostatic matrix for the management of bleeding in patients undergoing liver resection: results from 237 cases | Q94691185 | ||
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q21092360 | ||
| The state of US health, 1990-2010: burden of diseases, injuries, and risk factors | Q23909354 | ||
| Topical application of tranexamic acid for the reduction of bleeding | Q24201087 | ||
| Overview of Agents Used for Emergency Hemostasis | Q26746140 | ||
| Nanofibrous Snake Venom Hemostat | Q27300792 | ||
| A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis | Q27327667 | ||
| Self-propelled particles that transport cargo through flowing blood and halt hemorrhage | Q27340130 | ||
| Prehospital control of life-threatening truncal and junctional haemorrhage is the ultimate challenge in optimizing trauma care; a review of treatment options and their applicability in the civilian trauma setting | Q28069886 | ||
| Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial | Q28285511 | ||
| Comprehensive US government program for dried plasma development | Q30152155 | ||
| FloSeal use in endoscopic sinus surgery: effect on postoperative bleeding and synechiae formation. | Q30439633 | ||
| Intravenously administered nanoparticles increase survival following blast trauma | Q30584438 | ||
| Tranexamic acid, fibrinogen concentrate, and prothrombin complex concentrate: data to support prehospital use? | Q30705540 | ||
| Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data | Q30877971 | ||
| Fibrinolytic shutdown: fascinating theory but randomized controlled trial data are needed | Q31082543 | ||
| Platelets, platelet factors and platelet substitutes in the management of thrombocytopenic states. | Q33352078 | ||
| Control of severe intra-abdominal hemorrhage with an infusible platelet-derived hemostatic agent in a nonhuman primate (rhesus macaque) model | Q33429474 | ||
| Platelet Transfusion in Critical Care and Surgery: Evidence-Based Review of Contemporary Practice and Future Directions | Q33436810 | ||
| Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial | Q33733392 | ||
| Prehospital Tranexamic Acid Administration During Aeromedical Transport After Injury | Q90014610 | ||
| Resuscitative endovascular balloon occlusion of the aorta might be dangerous in patients with severe torso trauma: A propensity score analysis | Q40064767 | ||
| Tissue-Factor Targeted Peptide Amphiphile Nanofibers as an Injectable Therapy To Control Hemorrhage | Q40175254 | ||
| Nano hemostat solution: immediate hemostasis at the nanoscale. | Q40243410 | ||
| Prehospital use of hemostatic dressings by the Israel Defense Forces Medical Corps: A case series of 122 patients | Q40501584 | ||
| Freeze dried plasma and fresh red blood cells for civilian prehospital hemorrhagic shock resuscitation. | Q40909901 | ||
| Prehospital use of hemostatic dressings in emergency medical services in the Netherlands: A prospective study of 66 cases | Q40938915 | ||
| Adhesion of Blood Clots Can Be Enhanced When Copolymerized with a Macromer That Is Crosslinked by Coagulation Factor XIIIa | Q40966501 | ||
| Availability and use of hemostatic agents in prehospital trauma patients in Pennsylvania translation from the military to the civilian setting | Q40983653 | ||
| Intravenous hemostat: nanotechnology to halt bleeding. | Q41470605 | ||
| The FINISH-3 trial: a phase 3, international, randomized, single-blind, controlled trial of topical fibrocaps in intraoperative surgical hemostasis | Q41744356 | ||
| The evolving role of lyophilized plasma in remote damage control resuscitation in the French Armed Forces Health Service | Q42278629 | ||
| Safety evaluation of new hemostatic agents, smectite granules, and kaolin-coated gauze in a vascular injury wound model in swine | Q43162465 | ||
| Evaluation of lyophilized platelets as an infusible hemostatic agent in experimental non-compressible hemorrhage in swine | Q43298272 | ||
| Predictors of hypofibrinogenemia in blunt trauma patients on admission | Q43460429 | ||
| Management of External Hemorrhage in Tactical Combat Casualty Care: Chitosan-Based Hemostatic Gauze Dressings--TCCC Guidelines-Change 13-05. | Q43476050 | ||
| Hemostasis in a noncompressible hemorrhage model: an end-user evaluation of hemostatic agents in a proximal arterial injury | Q43506556 | ||
| A pilot study of the use of kaolin-impregnated gauze (Combat Gauze) for packing high-grade hepatic injuries in a hypothermic coagulopathic swine model | Q44074616 | ||
| Tranexamic acid in the prehospital setting: Israel Defense Forces' initial experience | Q44195932 | ||
| Real-world outcomes of hemostatic matrices in cardiac surgery | Q44391323 | ||
| An analysis of in-hospital deaths at a modern combat support hospital. | Q44533176 | ||
| Comparison of ChitoFlex®, CELOX™, and QuikClot® in control of hemorrhage | Q44946526 | ||
| Position statement of the American College of Surgeons Committee on Trauma on the National Academies of Sciences, Engineering and Medicine Report, A National Trauma Care System: Integrating Military and Civilian Trauma Systems to Achieve Zero Preven | Q45040496 | ||
| Fibrocaps for surgical hemostasis: two randomized, controlled phase II trials | Q45303687 | ||
| Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient | Q45375279 | ||
| Platelet-Microcapsule Hybrids Leverage Contractile Force for Targeted Delivery of Hemostatic Agents. | Q45868134 | ||
| Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency | Q45875602 | ||
| Use of freeze-dried plasma in French intensive care unit in Afghanistan | Q45892600 | ||
| Thrombosomes: a platelet-derived hemostatic agent for control of noncompressible hemorrhage. | Q45902625 | ||
| The epidemiology of noncompressible torso hemorrhage in the wars in Iraq and Afghanistan. | Q45915043 | ||
| Efficacy of hemostatic matrix and microporous polysaccharide hemospheres. | Q45976141 | ||
| Fibrin Sealant Patch (TachoSil) vs Oxidized Regenerated Cellulose Patch (Surgicel Original) for the Secondary Treatment of Local Bleeding in Patients Undergoing Hepatic Resection: A Randomized Controlled Trial | Q46190502 | ||
| Dried platelets in a swine model of liver injury | Q46323441 | ||
| Experimental optimization of an in situ forming hydrogel for hemorrhage control | Q46382198 | ||
| Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion | Q46809520 | ||
| Damage control management of experimental grade 5 renal injuries: further evaluation of FloSeal gelatin matrix | Q46969382 | ||
| Structural design of the dry fibrin sealant dressing and its impact on the hemostatic efficacy of the product | Q47336115 | ||
| Fibrinogen-is it a universal haemostatic agent? | Q47370348 | ||
| Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. | Q47382691 | ||
| An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis | Q47406040 | ||
| Biochemical characterization, stability, and pathogen safety of a new fibrinogen concentrate (fibryga®). | Q47553304 | ||
| Evaluation of XSTAT® and QuickClot® Combat Gauze® in a Swine Model of Lethal Junctional Hemorrhage in Coagulopathic Swine | Q47676044 | ||
| A prospective, randomized, controlled trial of the efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic surgery | Q47721935 | ||
| Hemostatic dressings in civil prehospital practice: 30 uses of QuikClot Combat Gauze. | Q47724568 | ||
| Advanced hemostatic dressings are not superior to gauze for care under fire scenarios | Q47788237 | ||
| Nano- and micro-materials in the treatment of internal bleeding and uncontrolled hemorrhage. | Q47825701 | ||
| III. Fibrinogen concentrate: clinical reality and cautious Cochrane recommendation | Q47905216 | ||
| ResQFoam for the Treatment of Non-Compressible Hemorrhage on the Front Line | Q48017193 | ||
| Hemostatic efficacy of a recombinant thrombin-coated polyglycolic acid sheet coupled with liquid fibrinogen, evaluated in a canine model of pulmonary arterial hemorrhage | Q48019395 | ||
| Control of Junctional Hemorrhage in a Consensus Swine Model With Hemostatic Gauze Products Following Minimal Training | Q48071057 | ||
| Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass | Q48144139 | ||
| Self-expanding foam for prehospital treatment of severe intra-abdominal hemorrhage: dose finding study | Q48348669 | ||
| Died of wounds on the battlefield: causation and implications for improving combat casualty care | Q48619093 | ||
| Celox (chitosan) for haemostasis in massive traumatic bleeding: experience in Afghanistan | Q48818438 | ||
| Hemostasis and nanotechnology | Q49247169 | ||
| French lyophilized plasma versus fresh frozen plasma for the initial management of trauma-induced coagulopathy: a randomized open-label trial. | Q49602510 | ||
| Comparison of the efficacy of two human fibrinogen concentrates to treat dilutional coagulopathy in vitro | Q49982193 | ||
| Use of French lyophilized plasma transfusion in severe trauma patients is associated with an early plasma transfusion and early transfusion ratio improvement | Q50045355 | ||
| Prehospital Application of Hemostatic Agents in Iraq and Afghanistan. | Q50064437 | ||
| Topical hemostatics for bleeding control in pre-hospital setting: Then and now. | Q50101257 | ||
| Death on the battlefield (2001-2011): implications for the future of combat casualty care | Q34314250 | ||
| Injuries | Q34342244 | ||
| A novel sponge-based wound stasis dressing to treat lethal noncompressible hemorrhage. | Q34357198 | ||
| Topical and effective hemostatic medicines in the battlefield | Q34467673 | ||
| Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries | Q34579964 | ||
| Prehospital Blood Product Resuscitation for Trauma: A Systematic Review | Q34675475 | ||
| Efficacy and safety of fibrinogen concentrate in trauma patients--a systematic review. | Q35089306 | ||
| Review of new topical hemostatic dressings for combat casualty care | Q35164702 | ||
| Celox-coated gauze for the treatment of civilian penetrating trauma: a randomized clinical trial. | Q35183352 | ||
| Synthetic Strategies for Engineering Intravenous Hemostats | Q35858739 | ||
| Hemostatic dressings for the first responder: a review | Q35923773 | ||
| Clotting Mimicry from Robust Hemostatic Bandages Based on Self-Assembling Peptides | Q36087858 | ||
| Clinical benefits and risk analysis of topical hemostats: a review | Q36290648 | ||
| Making sense of the preclinical literature on advanced hemostatic products | Q36419206 | ||
| A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery | Q36498487 | ||
| PolySTAT-modified chitosan gauzes for improved hemostasis in external hemorrhage. | Q36505721 | ||
| Evolution of fibrinogen-coated collagen patch for use as a topical hemostatic agent | Q36931821 | ||
| Pilot Randomized trial of Fibrinogen in Trauma Haemorrhage (PRooF-iTH): study protocol for a randomized controlled trial | Q37106075 | ||
| Designed amphiphilic peptide forms stable nanoweb, slowly releases encapsulated hydrophobic drug, and accelerates animal hemostasis | Q37146797 | ||
| The iTClamp controls junctional bleeding in a lethal swine exsanguination model | Q37206321 | ||
| Hemostatic Nanoparticles Improve Survival Following Blunt Trauma Even after 1 Week Incubation at 50 °C. | Q37278074 | ||
| The coagulopathy of trauma: a review of mechanisms | Q37292306 | ||
| A review of three stand-alone topical thrombins for surgical hemostasis. | Q37401469 | ||
| Efficacy of TachoSil a fibrin-based haemostat in different fields of surgery--a systematic review | Q37519655 | ||
| Role of fibrinogen in trauma-induced coagulopathy | Q37772358 | ||
| Pre-hospital haemostatic dressings: a systematic review | Q37805048 | ||
| Evaluation of topical hemostatic agents for combat wound treatment | Q37879028 | ||
| Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding | Q37941576 | ||
| Fibrinogen replacement therapy: a critical review of the literature | Q37966278 | ||
| Approaches to synthetic platelet analogs | Q38054986 | ||
| Haemostatic dressings in prehospital care | Q38060676 | ||
| Intravenous hemostats: challenges in translation to patients | Q38148673 | ||
| Freeze-dried plasma at the point of injury: from concept to doctrine | Q38148712 | ||
| Hemostatic strategies for traumatic and surgical bleeding | Q38168784 | ||
| An evidence-based review of the use of a combat gauze (QuikClot) for hemorrhage control | Q38193470 | ||
| Prothrombin complex concentrate in trauma patients | Q38279893 | ||
| Prothrombin complex concentrates in trauma and perioperative bleeding | Q38345109 | ||
| Topical hemostatic agents and dressings in the prehospital setting | Q38352793 | ||
| Application of current hemorrhage control techniques for backcountry care: part one, tourniquets and hemorrhage control adjuncts | Q38364085 | ||
| Experimental Animal Models of Traumatic Coagulopathy: A Systematic Review | Q38382403 | ||
| Tranexamic acid as part of remote damage-control resuscitation in the prehospital setting: A critical appraisal of the medical literature and available alternatives. | Q38498959 | ||
| Injectable hemostatic adjuncts in trauma: Fibrinogen and the FIinTIC study | Q38498963 | ||
| Use of local pro-coagulant haemostatic agents for intra-cavity control of haemorrhage after trauma | Q38513918 | ||
| Human dose confirmation for self-expanding intra-abdominal foam: A translational, adaptive, multicenter trial in recently deceased human subjects | Q38532226 | ||
| Cause of trauma-induced coagulopathy | Q38679764 | ||
| Coagulation management in trauma-associated coagulopathy: allogenic blood products versus coagulation factor concentrates in trauma care | Q38702565 | ||
| Use of tranexamic acid in combat casualties. Experience of the Spanish medical corps. Clinical series and literature review | Q38711865 | ||
| A systematic review of the use of resuscitative endovascular balloon occlusion of the aorta in the management of hemorrhagic shock. | Q38713490 | ||
| Trauma-associated bleeding: management of massive transfusion | Q38719922 | ||
| QuikClot® Combat Gauze® Use by Ground Forces in Afghanistan The Prehospital Trauma Registry Experience | Q38733983 | ||
| Pre Hospital Administration of Freeze Dried Plasma, is it the solution for Trauma Casualties? | Q38738664 | ||
| Hydrophobically modified chitosan gauze: a novel topical hemostat | Q38782381 | ||
| Dried plasma: state of the science and recent developments | Q38813894 | ||
| Surgical adjuncts to noncompressible torso hemorrhage as tools for patient blood management | Q38813909 | ||
| Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review | Q38816166 | ||
| Safety of the long-term application of QuikClot Combat Gauze, ChitoGauze PRO and Celox Gauze in a femoral artery injury model in swine - a preliminary study. | Q38834903 | ||
| Halting hemorrhage with self-propelling particles and local drug delivery | Q38840359 | ||
| Intra-abdominal packing with laparotomy pads and QuikClot™ during damage control laparotomy: A safety analysis. | Q38911758 | ||
| Noncompressible Torso Hemorrhage. | Q39022528 | ||
| Bleeding Control Using Hemostatic Dressings: Lessons Learned | Q39187807 | ||
| Tactical Combat Casualty Care and Wilderness Medicine: Advancing Trauma Care in Austere Environments | Q39244348 | ||
| Comparison of new hemostatic granules/powders with currently deployed hemostatic products in a lethal model of extremity arterial hemorrhage in swine | Q39307794 | ||
| Battlefield administration of tranexamic acid by combat troops: a feasibility analysis | Q39327118 | ||
| Remote Damage Control Resuscitation in Austere Environments. | Q39364087 | ||
| Tranexamic Acid Use in Prehospital Uncontrolled Hemorrhage | Q39364102 | ||
| The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial | Q39401875 | ||
| A multi-institutional study of hemostatic gauze and tourniquets in rural civilian trauma | Q39712664 | ||
| Evaluation of the efficiency under current use of human fibrinogen concentrate in trauma patients with life-threatening hemorrhagic disorders. | Q39715243 | ||
| Development of a standard swine hemorrhage model for efficacy assessment of topical hemostatic agents | Q39721860 | ||
| Coagulation factor concentrate-based therapy for remote damage control resuscitation (RDCR): a reasonable alternative? | Q39834024 | ||
| Evaluation of a new generation platelet-derived hemostatic agent in a rabbit thrombocytopenic model | Q50245656 | ||
| Fibrinogen level deteriorates before other routine coagulation parameters and massive transfusion in the early phase of severe trauma: a retrospective observational study. | Q50453538 | ||
| Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. | Q50512736 | ||
| Peptide valency plays an important role in the activity of a synthetic fibrin-crosslinking polymer. | Q50915888 | ||
| Use of FloSeal matrix hemostatic agent in partial splenectomy after penetrating trauma. | Q51030414 | ||
| The potential utility of fibrin sealant dressing in repair of vascular injury in swine. | Q51084940 | ||
| Evaluation of FloSeal as a potential intracavitary hemostatic agent. | Q51257135 | ||
| Management of External Hemorrhage in Tactical Combat Casualty Care: The Adjunctive Use of XStat™ Compressed Hemostatic Sponges: TCCC Guidelines Change 15-03. | Q51393014 | ||
| Hemostatic efficacy of a fibrin sealant dressing in an animal model of kidney injury. | Q51496493 | ||
| Application of a granular mineral-based hemostatic agent (QuikClot) to reduce blood loss after grade V liver injury in swine. | Q51607720 | ||
| The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis. | Q51736474 | ||
| Intravenous administration of synthetic platelets (SynthoPlateTM) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis. | Q51740307 | ||
| Randomized trial of a dry-powder, fibrin sealant in vascular procedures. | Q51817113 | ||
| Micro- and nano-motors: the new generation of drug carriers. | Q52655707 | ||
| The effect of fibrinogen concentrate and fresh frozen plasma on the outcome of patients with acute traumatic coagulopathy: A quasi-experimental study. | Q52729007 | ||
| Prehospital haemostatic dressings for trauma: a systematic review. | Q53283693 | ||
| Double-blinded, placebo-controlled study of early tranexamic acid treatment in swine uncontrolled hemorrhage model. | Q53804719 | ||
| Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial. | Q53840501 | ||
| A Fibrin Cross-linking Polymer Enhances Clot Formation Similar to Factor Concentrates and Tranexamic Acid in an in vitro Model of Coagulopathy. | Q55038787 | ||
| Pre-hospital intra-osseous freeze dried plasma transfusion: a case report. | Q55066123 | ||
| Enhancing clot properties through fibrin-specific self-cross-linked PEG side-chain microgels | Q56365154 | ||
| Initial Evaluation of the Efficacy and Safety of In-Hospital Expandable Hemostatic Minisponge Use In Penetrating Trauma | Q57798301 | ||
| The Impact of Pre Hospital Administration of Freeze Dried Plasma on Casualty Outcome | Q57798303 | ||
| Efficacy of prehospital administration of tranexamic acid in trauma patients: A meta-analysis of the randomized controlled trials | Q58651217 | ||
| A systematic review on the use of topical hemostats in trauma and emergency surgery | Q58695090 | ||
| Engineering Intravenously Administered Nanoparticles to Reduce Infusion Reaction and Stop Bleeding in a Large Animal Model of Trauma | Q60998516 | ||
| Injectable antibacterial conductive nanocomposite cryogels with rapid shape recovery for noncompressible hemorrhage and wound healing | Q61136418 | ||
| What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies | Q61805710 | ||
| The use of new procoagulants in blunt and penetrating trauma. | Q64931597 | ||
| Hemostatic efficacy of a fibrin sealant-based topical agent in a femoral artery injury model: a randomized, blinded, placebo-controlled study | Q73651801 | ||
| Effect of fibrin bandage fibrinogen concentration on blood loss after grade V liver injury in swine | Q73659115 | ||
| Efficacy of a dry fibrin sealant dressing for hemorrhage control after ballistic injury | Q74076197 | ||
| The preparation and clinical administration of lyophilized platelet material to children with acute leukemia and aplastic anemia | Q74258254 | ||
| Plasma-derived biological medicines used to promote haemostasis | Q81194578 | ||
| Biochemical comparison of seven commercially available prothrombin complex concentrates | Q81762781 | ||
| Clot-Inducing Minerals Versus Plasma Protein Dressing for Topical Treatment of External Bleeding in the Presence of Coagulopathy | Q82417083 | ||
| Against: Fibrinogen concentrate for management of bleeding: against indiscriminate use | Q83142220 | ||
| Development of in situ-forming hydrogels for hemorrhage control | Q83612026 | ||
| Comparison of 10 hemostatic dressings in a groin puncture model in swine | Q84450618 | ||
| Development of a lethal, closed-abdomen grade V hepato-portal injury model in non-coagulopathic swine | Q84869107 | ||
| Use of Tranexamic Acid in Bleeding Combat Casualties | Q85678930 | ||
| In vitro and in vivo hemostatic capabilities of a functionally integrated platelet-mimetic liposomal nanoconstruct | Q85982195 | ||
| Comparison of novel hemostatic dressings with QuikClot combat gauze in a standardized swine model of uncontrolled hemorrhage | Q87143950 | ||
| Self-expanding foam for prehospital treatment of intra-abdominal hemorrhage: 28-day survival and safety | Q87665215 | ||
| Fibrinogen Concentrate in the Special Operations Forces Environment | Q87689564 | ||
| Platelets loaded with liposome-encapsulated thrombin have increased coagulability | Q88156437 | ||
| Combined intravenous, topical and oral tranexamic acid administration in total knee replacement: Evaluation of safety in patients with previous thromboembolism and effect on hemoglobin level and transfusion rate | Q88654705 | ||
| RDCR Symposium fifth-year anniversary edition: global prehospital care rooted in a history of military innovation | Q89270650 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 13 | |
| P577 | publication date | 2020-03-25 | |
| P1433 | published in | Military Medical Research | Q27726127 |
| P1476 | title | Hemostatic agents for prehospital hemorrhage control: a narrative review | |
| P478 | volume | 7 |
| Q98292398 | A polymer-based systemic hemostatic agent | cites work | P2860 |
Search more.